AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $572,000 | +14200.0% | 79,000 | +13066.7% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 600 | -43.7% | 0.00% | – |
| Q1 2019 | $2,000 | -80.0% | 1,066 | -73.2% | 0.00% | – |
| Q4 2018 | $10,000 | -41.2% | 3,981 | 0.0% | 0.00% | – |
| Q3 2018 | $17,000 | -43.3% | 3,981 | -20.1% | 0.00% | – |
| Q2 2018 | $30,000 | -16.7% | 4,981 | 0.0% | 0.00% | – |
| Q1 2018 | $36,000 | -12.2% | 4,981 | 0.0% | 0.00% | – |
| Q4 2017 | $41,000 | -2.4% | 4,981 | +25.1% | 0.00% | – |
| Q3 2017 | $42,000 | -4.5% | 3,981 | 0.0% | 0.00% | – |
| Q2 2017 | $44,000 | +12.8% | 3,981 | 0.0% | 0.00% | – |
| Q1 2017 | $39,000 | – | 3,981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |